A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis

Annals of the New York Academy of Sciences

Volumn 1089, Issue , 2006, Pages 343-372

  Offner, Halina ^a,b   Polanczyk, Magdalena ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

EAE; Estrogen; Estrogen receptors; FoxP3; Immunoregulation; Multiple sclerosis; Neuroprotection; Treg

Indexed keywords

CHEMOKINE; ESTRADIOL; ESTRADIOL RECEPTOR; ESTRIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCLONAL ANTIBODY CD3; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; PLACEBO; RANTES; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; ESTROGEN;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; SEX RATIO; SURVIVAL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

MUS;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRADIOL; ESTROGENS; HUMANS; MICE; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, REGULATORY;

EID: 33847791448     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1386.021     Document Type: Conference Paper

References (113)

1. MASON, D. & F. POWRIE. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10: 649-655.
2. OFFNER, H. et al. 2000. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 105: 1465-1472.
3. BEBO, B.F. et al. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166: 2080-2089.
4. ITO, A. et al. 2001. Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167: 542-552.
5. MATEJUK, A. et al. 2000. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein. J. Immunol. 164: 3924-3931.
6. POLANCZYK, M. et al. 2003. The protective effect of 17B-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-α. Am. J. Pathol. 163: 1599-1605.
7. WHITACRE, C.C.. 2001. Sex differences in autoimmune disease. Nature Immunol. 2: 777-780.
8. BEBO, B.F., A.A. VANDENBARK & H. OFFNER. 1996. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45: 680-689.
9. VOSKUHL, R.R. et al. 1996. Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis. Ann. Neurol. 39: 724-731.
10. BLAZKOVEC, A.A. & M.W. ORSINI. 1976. Ontogenetic aspects of sexual dimorphism and the primary immune response to sheep erythrocytes in hamster from prepuberty through senescence. Intl. Arch. Allergy Appl. Immunol. 50: 55-60.
11. OKA, M. & U. VAINIO. 1966. Effect of pregnancy on the prognosis and serology of RA. Acta Rheumatol. Scand. 12: 47-53.
12. CONFAVREUX, C. et al. 1998. Rate of pregnancy-related relapse in multiple sclerosis. New Engl. J. Med. 339: 285-291.
13. GARSENSTEIN, M., V.E. POLLAK, & R.M. KARK. 1962. Systemic lupus erythematosus and pregnancy. New Engl. J. Med. 267: 917-921.
14. OSTENSEN, M. & G.A. HUSBY. 1983. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis & Rheumatol. 25: 1155-1160.
15. ROUBINIAN, J.R., R. PAPOIAN & N. TALAL. 1977. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J. Clin. Inv. 59: 1066-1071.
16. JUNGERS, P., M. DOUGADOS, C. PELISSIER, et al. 1982. Influence of oral contraceptive therapy on activity of systemic lupus erythematosus. Arthritis & Rheumatol. 125: 618-625.
17. ANSAR, A.S. & W.J. PENHALE. 1982. The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin. Exp. Immunol. 48: 367-372.
18. OKAYASU, I., Y.M. KONG & N.R. ROSE. 1981. Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol. 20: 240-246.
19. STERNBERG, A.D., P.A. SMATHERS & W.B. BOEGEL. 1980. Effects of sex hormones on autoantibody production of NZB mice and modification by environmental factors. Clin. Immunol. Immunopathol. 17: 562-570.
20. MILCH, D.R. & M.E. GERSHWIN. 1981. Murine autoimmune hemolytic anemia via xenogeneic erythrocyte immunization. III. Differences in sex. Clin. Immunol. Immunopathol. 18: 1-7.
21. ARIGA, H., J. EDWARDS & D.A. SULLIVAN. 1989. Androgen control of autoimmune expression in lacrimal gland of MRL-MP/lpr-lpr mice. Clin. Immunol. Immunopathol. 53: 499-504.
22. LARSON, P. & R. HOLMDAHL. 1987. Estrogen-induced suppression of collagen arthritis. II. Treatment of rats suppresses development of arthritis but does not affect the anti-type II collagen humoral response. Scand. J. Immunol. 27: 579-586.
23. TOIVANEN, P., H. SUKALA, P. LAIHO, & T. PAAVLIAINES. 1967. Suppression of adjuvant arthritis by estrone in adrenalectomized and ovarectomized rats. Experentia 23: 560-568.
24. TROOSTER, W.J. et al. 1993. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: an immunological study in the Lewis rat. Intl. Arch. Allergy & Immunol. 102: 133-140.
25. JANSSON, L., T. OLSSON & R. HOLMDAHL. 1994. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol. 53: 203-207.
26. EVRON, S., T. BRENNER & O. ABRAMSKY. 1984. Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am. J. Reprod. Immunol. 5: 109-114.
27. MERTIN, L.A. & V.M. RUMJANEK. 1985. Pregnancy and susceptibility of Lewis rats to experimental allergic encephalomyelitis. J. Neurol. Sci. 68: 15-21.
28. VOSKUHL, R.R. & K. PALASZYNSKI. 2001. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258-270.
29. SMITH, M.E. & N.L. ELLER. 1996. Gender influences EAE both before and after sexual maturation. FASEB J. 10: A1353.
30. STIMSON, W.H. & I.C. HUNTER. 1976. An investigation into the immunosuppressive properties of estrogen. J. Endocrinol. 69: 42-50.
31. PAAVONEN, T., L.C. ANDERSON & H. ADLERCREUTZ. 1981. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 154: 1935-1941.
32. TAUBE, M., S. SVENSSON & H. CARLSTEN. 1998. T lymphocytes are not the target for estradiol-mediated suppression of DTH in reconstituted female severe combined immunodeficient (SCID) mice. Clin. Exp. Immunol. 114: 147-153.
33. SALEM, M.L. et al. 2000. β-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int. Arch. Allergy. Immunol. 121: 161-169.
34. WYLIE, F.A. & J.R. KENT. 1977. Immunosuppression by sex steroid hormones. I. The effect upon PHA and PPD stimulated lymphocytes. Clin. Exp. Immunol. 27: 407-412.
35. HOLDSTOCK, G., B.F. CHASTENAY & E.L. KRAWITT. 1982. Effect of testosterone, oestradiol and progesterone on immune regulation. Clin. Exp. Immunol. 47: 449-456.
36. MCEWEN, B.S.. 2001. Genome and hormones: gender differences in physiology. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91: 2785-2801.
37. CZLONKOWSKA, A., A. CIESLELSKA & I. JONIEC. 2003. Influence of estrogens on neurodegenerative processes. Med. Sci. Monit. 9: 247-256.
38. TORAN-ALLERAND, C.D., M. SINGH & G. SETALO. 1999. Novel mechanisms of estrogen action in the brain: new players in an old story. Frontiers Neuroendocrinol. 20: 97-121.
39. MIRANDA, R.C. & C.D. TORAN-ALLERAND. 1993. Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions. Proc. Natl. Acad. Sci. USA. 90: 6439-6443.
40. ZWAIN, I.H. & S.S. YEN. 1999. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140: 3843-3852.
41. ARVANITIS, D.N. et al. 2004. Membrane-associated estrogen receptor and caveolin-1 present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res. 75: 603-613.
42. MALOY, K.J. & F. POWRIE. 2001. Regulatory T cells in the control of immune pathology. Nature Immunol. 2: 816-822.
43. RONCAROLO, M.G. & M.K. LEVINGS. 2000. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12: 676-683.
44. SHEVACH, E.M.. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-449.
45. SAKAGUCHI, S.. 2000. Animal models of autoimmunity and their relevance to human diseases. Curr. Opin Immunol. 12: 684-690.
46. SAKAGUCHI, S. et al. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
47. ASANO, M. et al. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184: 387-396.
48. READ, S., V. MALMSTROM & F. POWRIE. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 + CD4 + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
49. KOHM, A.P. et al. 2002. CD4 + CD25 + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
50. STEVENS, L.A. & D. MASON. 2000. CD25 is a marker for CD4 + thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25 + and CD25- subpopulations. J. Immunol. 165: 3105-3110.
51. GREEN, E.A., Y. CHOI & R.A. FLAVELL. 2002. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16: 183-191.
52. BELKAID, Y. et al. 2002. CD4 + CD25 + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
53. TAKAHASHI, T. et al. 1998. Immunologic self-tolerance maintained by CD25 + CD4 + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
54. THORNTON, A.M. & E.M. SHEVACH. 1998. CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
55. SURI-PAYER, E. et al. 1998. CD4 + CD25 + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160: 1212-1218.
56. STEVENS, L.A. et al. 2001. Human CD4 + CD25 + thymocytes and peripheral T cells have immune suppressive activity. Eur. J. Immunol. 31: 1247-1254.
57. TAAMS, L.S. et al. 2001. Human anergic/suppressive CD4 + CD25 + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31: 1122-1131.
58. DIECKMANN, D. et al. 2001. Ex vivo isolation and characterization of CD4 + CD25 + T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
59. LEVINGS, M.K., R. SANGREGORIO & M.-G. RONCAROLO. 2001. Human CD25 + CD4 + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1301.
60. MURAKAMI, M. et al. 2002. CD25 + CD4 + T cells contribute to the control of memory CD8 + T cells. Proc. Natl. Acad. Sci. USA. 99: 8832-8837.
61. MCHUGH, R.S. et al. 2002. CD4 + CD25 + immunoregulatory T cells: gene expression analysis reveals a functional role for glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
62. SHIMIZU, J. et al. 2002. Stimulation of CD25 + CD4 + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3: 135-142.
63. SALOMON, B. et al. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4 + CD25 + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
64. TAKAHASHI, T. et al. 2000. Immunologic self-tolerance maintained by CD25 + CD4 + regulatory T cells constitutively expressing cytotoxic lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-309.
65. CHAMBERS, C.A. et al. 2001. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19: 565-594.
66. KINGSLEY, C.I. et al. 2002. CD25 + CD4 + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunogregulation of alloresponses. J. Immunol. 168: 1080-1086.
67. NAKAMURA, K., A. KITANI & W. STROBER. 2001. Cell contact-dependent immunosuppression by CD4 (+) CD25 (+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194: 629-644.
68. ERMANN, J. et al. 2001. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J. Immunol. 167: 4271-4275.
69. ZHANG, X. et al. 2001. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 167: 4245-4253.
70. ZHENG, S.G. et al. 2002. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4 + CD25- precursors. J. Immunol. 169: 4183-4189.
71. JONULEIT, H. et al. 2002. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196: 255-260.
72. ANNACKER, O. et al. 2001. CD25 + CD4 + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166: 3008-3018.
73. PONTOUX, C., A. BANZ & M. PAPIERNIK. 2002. Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Intl. Immunol. 14: 233-239.
74. JONULEIT, H. & E. SCHMITT. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 6323-6327.
75. KHATTRI, R. et al. 2003. An essential role for Scurfin in CD4 + CD25 + T regulatory cells. Nature Immunol. 4: 337-342.
76. HORI, S., T. NOMURA & S. SAKAGUCHI. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
77. FONTENOT, J.D., M.A. GAVIN & A.Y. RUDENSKY. 2003. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nature Immunol. 4: 330-336.
78. FRITZ, R.B., C.-H.J. CHOU & D.E. MCFARLIN. 1983. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/JxPL/J)F1 mice by myelin basic protein and its peptides: Localization of a second encephalitogenic determinant. J. Immunol. 130: 191-196.
79. TROTTER, J.L. et al. 1987. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79: 173-184.
80. MCRAE, B.L. et al. 1992. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38: 229-235.
81. PATERSON, P.Y. & R.H. SWANBORG. 1988. Demyelinating diseases of the central and peripheral nervous systems. In Immunological Diseases. M. Sampter, D.W. Talmage, M.M. Frank, K.F. Austen, & H.N. Claman, Eds.: 1877-1916. Little, Brown and Co. Boston.
82. KUCHROO, V.K. et al. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor Vβ usage. J. Immunol. 148: 3776-3782.
83. BERNARD, C.C.A.. 1976. Experimental autoimmune encephalitis in mice: Genetic control of susceptibility. J. Immunogenetics 3: 263-270.
84. ARNON, R.. 1981. Experimental allergic encephalomyelitis- susceptibility and suppression. Immunol. Rev. 55: 5-9.
85. LINTHICUM, D. & J. FRELLINGER. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 155: 31-38.
86. MONTGOMERY, I.N. & H.C. RAUCH. 1982. Experimental autoimmune encephalomyelitis (EAE) in mice: primary control of EAE susceptibility is outside the H-2 complex. J. Immunol. 128: 421-429.
87. MA, R.Z. et al. 2002. Identification of Bphs, and autoimmune disease locus, as histamine receptor H1. Science 297: 620-623.
88. MATEJUK, A. et al. 2001. 17β-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental encephalomyelitis. J. Neurosci. Res. 65: 529-542.
89. KRAKOWSKI, M. & T. OWENS. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26: 1641-1646.
90. WILLENBORG, D.O. et al. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157: 3223-3227.
91. SEGAL, B.M., B.K. DWYER & E.M. SHEVACH. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187: 537-546.
92. MATEJUK, A. et al. 2003. 17β-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis. Archi. Immunol. Ther. Exp. 51: 185-193.
93. MATEJUK, A. et al. 2002. Evaluation of the effects of 17B-estradiol (17B-E2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray. Endocrinology 143: 313-319.
94. KLINKERT, W.E. et al. 1997. TNF-alpha receptor fusion protein prevents EAE and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72: 163-168.
95. LIU, H.Y., A. BUENAFE, A. MATEJUK, et al. 2002. Estrogen inhibition of EAE may involve differential effects on mature vs. immature dendritic cells. J. Neurosci. Res. 70: 238-248.
96. POLANCZYK, M.J. et al. 2006. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84: 370-378.
97. LIU, H. et al. 2003. Estrogen receptor α mediates estrogen's immune protection in autoimmune disease. J. Immunol. 171: 6936-6940.
98. VEGETO, E. et al. 2003. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA 100: 9614-9619.
99. COUSE, J.F., M.M. YATES, V.R. WALKER & K.S. KORACH. 2003. Characterization of the hypothalamic-pituitary- gonadal (HPG) axis in estrogen receptor null mice reveals hypergonadism and endocrine sex-reversal in females lacking Era but not Erβ. Mol. Endocrinol. 17: 1039-1053.
100. BEBO, B.F., J.C. SCHUSTER, A.A. VANDENBARK & H. OFFNER. 1999. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162: 35-40.
101. LUBHAN, D.B., J.S. MOYER, T.S. GOLDING, et al. 1993. Alterations of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA. 90: 11162-11166.
102. KREGE, J.H., J.B. HODGIN, J.F. COUSE, et al. 1998. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc. Natl. Acad. Sci. USA. 95: 15677-15682.
103. ERLANDSSON, M.C., C. OHLSSON, J-A GUSTAFSSON H. CARLSTEN. 2001. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103: 17-25.
104. YELLAYI, S.T.C., C. TEUSCHER, J.A. WOODS, et al. 2000. Normal development of thymus in male and female mice requires estrogen/estrogen receptor-apha signaling pathway. Endocrine. 12: 207-213.
105. STAPLES, J.E., T.A. GASIEWICZ, N.C. FIORE, et al. 1999. Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J. Immunol. 163: 4168-4174.
106. POLANCZYK, M.J. et al. 2004. Cutting edge: estrogen drives expansion of the CD4 + CD25 + regulatory T cell compartment. J. Immunol. 173: 2227-2230.
107. OFFNER, H., G.A. HASHIM & A.A. VANDENBARK. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251: 430-432.
108. OFFNER, H. et al. 1998. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 mice. J. Immunol. 161: 2178-2186.
109. MATEJUK, A. et al. 2003. Differential expression of TGF-β3 is associated with protection against experimental autoimmune encephalomyelitis. Cytokine 25: 45-51.
110. JANSSON, L. & R. HOLMDAHL. 1998. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47: 290-301.
111. POLMAN, C.H. & B.M.J. UITDEHAAG. 2003. New and emerging treatment options for multiple sclerosis. Lancet Neurol. 2: 563-566.
112. BJARTMAR, C., J.R. WUJEK & B.D. TRAPP. 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206: 165-171.
113. SICOTTE, N.L. et al. 2002. Treatment of multiple sclerosis with pregnancy hormone estriol. Ann. Neurol. 52: 421-428.